MDT
97.97
-0.41%↓
VEEV
301.82
-1.22%↓
A
141.04
+1.79%↑
HQY
92.06
+4.03%↑
PHR.US
23.23
-0.43%↓
MDT
97.97
-0.41%↓
VEEV
301.82
-1.22%↓
A
141.04
+1.79%↑
HQY
92.06
+4.03%↑
PHR.US
23.23
-0.43%↓
MDT
97.97
-0.41%↓
VEEV
301.82
-1.22%↓
A
141.04
+1.79%↑
HQY
92.06
+4.03%↑
PHR.US
23.23
-0.43%↓
MDT
97.97
-0.41%↓
VEEV
301.82
-1.22%↓
A
141.04
+1.79%↑
HQY
92.06
+4.03%↑
PHR.US
23.23
-0.43%↓
MDT
97.97
-0.41%↓
VEEV
301.82
-1.22%↓
A
141.04
+1.79%↑
HQY
92.06
+4.03%↑
PHR.US
23.23
-0.43%↓
24h
Actual
Mínimo
2.87
Máximo
3.04
Recomendaciones | Comprar |
---|---|
Estimación a 12 Meses | +375.41% upside |
Próximas Ganancias | 12 nov 2025 |
---|
Resultados pasados no son un indicador fiable de resultados futuros.
1 oct 2025, 15:07 UTC
Fortress Biotech Shares Drop After FDA Letter for CUTX-101 Manufacturing Facility
DJ
Leer
10 mar 2025, 02:12 UTC
Checkpoint Controlling Shareholder Fortress Has Agreed to Vote in Favor of Transaction >524715.BY
DJ
Leer
10 mar 2025, 02:12 UTC
Sun Pharma, Checkpoint Transaction Expected to Complete in 2Q 2025 >524715.BY
DJ
Leer
10 mar 2025, 02:11 UTC
Sun Pharma, Checkpoint, Fortress Biotech Enter Into Royalty Agreement >524715.BY
DJ
Leer
10 mar 2025, 02:11 UTC
Checkpoint Shareholders Entitled to Receive Up to Additional $0.70 if Cosibelimab if Approved in EU Prior to Certain Deadlines >524715.BY
DJ
Leer
10 mar 2025, 02:10 UTC
Checkpoint Shareholders to Receive Upfront Cash Payment of $4.10/Share, Contingent Value Right >524715.BY
DJ
Leer
10 mar 2025, 02:10 UTC
Sun Pharma to Acquire Checkpoint Therapeutics >524715.BY CKPT
DJ
Leer
10 mar 2025, 02:06 UTC
Sun Pharma To Acquire Checkpoint Therapeutics >524715.BY CKPT
DJ
Leer
Cambio de precio
By TipRanks
Estimación a 12 Meses
Media 14.5 USD 375.41%
Máximo 17 USD
Mínimo 12 USD
De acuerdo con 2 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Fortress Biotech Inc Dist en los últimos 3 meses.
By TipRanks
Comprar
2 ratings
2
Comprar
0
Mantener
0
Vender
De acuerdo con 2 analistas que ofrecen calificaciones bursátiles a para Fortress Biotech Inc Dist en los últimos 3 meses.
$